An adult sitting comfortably on a bench surrounded by leafy greenery in natural daylight.

Cannabis and Physical Health: Evidence and Limits | NM

Cannabis and physical health are connected through immediate impairment, smoke exposure, cardiovascular effects, and other concerns. The evidence is stronger for some effects than others. Separate from our cannabis use disorder treatment overview, this discussion focuses on what physical-health research establishes, what remains uncertain, and why those distinctions matter.

You may use cannabis for relaxation, pain, sleep, or another symptom and still have questions about its effects on your body. Feeling relief does not settle every safety question, and a concerning research finding does not diagnose an illness in you. Most of the evidence discussed here concerns cannabis containing intoxicating amounts of tetrahydrocannabinol, or THC. Product characteristics, other substances, medical conditions, and individual differences can affect the response. Our resource on checking online recovery health claims offers related context for reading health information without treating a headline as a personal medical conclusion.

Written by Tim Francis, SUD Content Specialist. Tim is a nonclinical author. This guide supports discussion with qualified professionals.

How can cannabis affect physical function and the body shortly after use?

THC-containing cannabis can temporarily impair thinking, memory, time perception, and body movement while increasing heart rate or appetite. These physical effects differ from the patterns discussed in our cannabis use disorder treatment overview. Checking online recovery health claims helps separate a short-term effect from an unsupported claim of permanent damage.

The National Institute on Drug Abuse, or NIDA, describes altered body movement and thinking as effects of cannabis intoxication. Physical function includes the ability to coordinate movement with attention and judgment. A change in these abilities matters during driving, operating equipment, or another task that requires an accurate response to changing conditions.

NIDA also describes increased appetite, elevated heart rate, and possible respiratory problems. People do not all experience these effects in the same way. Factors that can change the response include:

  • The amount consumed and the concentration of THC.
  • Product ingredients and how cannabis enters the body.
  • Other drugs or substances taken at the same time.
  • Underlying medical conditions, age, and prior cannabis experience.

These differences make a friend's experience an unreliable forecast of your own. They also limit what can be concluded from one previous occasion. Edible products can take longer to produce noticeable effects, according to NIDA. That delay is a product-related concern, not evidence that a person is unaffected or that a particular method is safe.

Intoxication can also involve anxiety, panic, or changes in perception. Those effects can overlap with physical discomfort, but they should not become an automatic explanation for every new symptom. Repeated vomiting is another distinct concern: NIDA describes cannabinoid hyperemesis syndrome after long-term, heavy use. Our explanation of cannabis and repeated vomiting addresses that narrower issue without making every episode of nausea a cannabis-related diagnosis.

What does research show about cannabis smoke and lung health?

Cannabis smoke contains many of the same toxins, irritants, and cancer-causing substances as tobacco smoke. Long-term smoking is associated with airway problems, although tobacco co-use complicates interpretation. Our cannabis use disorder overview and guide to checking health claims provide context for separating a respiratory finding from an individual diagnosis.

NIDA's cannabis research summary states that smoking cannabis can harm lung tissue. It links long-term smoking with large-airway inflammation, increased airway resistance, lung hyperinflation, and chronic bronchitis. Airway inflammation refers to irritation and swelling in the breathing passages. Increased airway resistance means greater opposition to airflow, while hyperinflation describes excess air remaining in the lungs.

These findings concern different aspects of respiratory health. They should not be compressed into a claim that every person who smokes cannabis has the same lung disease. They also do not provide a symptom-based way to determine the amount of lung injury someone has experienced.

Tobacco use is a major interpretation problem. Many people in cannabis studies also use tobacco, making it harder to separate the contribution of each exposure. That limitation does not erase the harmful substances found in cannabis smoke. It means that attributing a specific long-term outcome to cannabis alone requires care.

Similarly, overlapping smoke chemicals do not establish that cannabis and cigarettes produce identical risks at identical levels of use. The evidence supports concern about inhaled smoke without supporting a simple one-for-one comparison. Nor does a discussion of smoke establish that a nonsmoked product is safe overall: impairment, cardiovascular effects, and medication concerns are separate questions.

For someone with breathing symptoms, the useful distinction is between a plausible exposure-related concern and a confirmed diagnosis. A medical assessment can consider cannabis, tobacco, existing respiratory conditions, and other possible explanations together. General addiction counseling can address patterns of substance use, but it does not replace evaluation of lung symptoms.

What is known and uncertain about cannabis and cardiovascular health?

Cannabis can raise heart rate and blood pressure shortly after use. Studies also report associations with heart attack, stroke, and abnormal heart rhythms, but a direct causal connection remains uncertain. For people treating symptoms, chronic pain and substance use counseling provides related context; checking health claims helps distinguish association from proof.

NIDA distinguishes immediate cardiovascular changes from longer-term disease associations. Heart rate is how frequently the heart beats. Blood pressure concerns the pressure of blood against artery walls. An increase in either measure shortly after use is a different finding from evidence about the likelihood of a later heart attack or stroke.

An association means that cannabis use and a health outcome occur together in a research population more often than expected under the comparison being studied. By itself, that does not establish that cannabis is the sole cause, identify every contributing factor, or predict what will happen to an individual.

Different cardiovascular findings answer different questions
FindingWhat it supportsWhat it does not establish
Increased heart rate shortly after useCannabis can produce an immediate physical change.That a faster pulse proves heart damage.
Increased blood pressure shortly after useCannabis can affect circulation-related measurements.That one episode diagnoses a lasting blood-pressure condition.
Associations with heart attack, stroke, or abnormal rhythmsThese outcomes deserve continued investigation.That cannabis alone caused a particular person's illness.
Uncertainty about a direct connectionOther contributing factors still require study.That cannabis has been shown to carry no cardiovascular concern.

The table reflects distinctions in NIDA's summary, not a personal risk calculator. It cannot turn age, frequency of use, or a symptom into an individual probability.

Two opposite interpretations go beyond the evidence: declaring that cannabis necessarily causes cardiovascular disease in everyone who uses it, and dismissing every association because causation remains unsettled. A more accurate position recognizes the documented immediate effects, takes longer-term findings seriously, and preserves uncertainty about how different factors contribute.

Why can age, existing conditions, and other medicines change cannabis-related concerns?

Age, existing medical conditions, and other medicines can change how cannabis affects you. NIDA identifies possible interactions with warfarin, opioids, and benzodiazepines, including medicines older adults may take. Chronic pain and substance use counseling addresses a related concern, while our cannabis treatment overview explains support when use itself becomes difficult to control.

Older adults may use cannabis in an effort to manage pain, sleep problems, or other symptoms. NIDA describes these self-treatment patterns, while also identifying age and underlying conditions as factors in cannabis response. A reason for using a substance and evidence that it is appropriate for a particular person are different things.

Possible medicine interactions deserve attention even when cannabis use is occasional or symptom relief feels meaningful. NIDA's examples are not a complete interaction list. They also do not mean that each named medicine has the same interaction, that every person will experience harm, or that a reliable interaction magnitude can be assigned from general information.

Three separate issues can be relevant:

  • The health condition someone hopes cannabis will relieve.
  • The effects and limitations of the cannabis exposure itself.
  • Possible interactions with other medicines or substances.

Keeping those issues separate prevents a misleading shortcut. For example, evidence that cannabis may help some forms of pain does not answer every question about its use alongside an existing prescription. It also does not establish that all products are interchangeable. Product formulations and medical approvals require their own evidence; the label “medical” does not settle the full assessment.

A qualified clinician can consider the actual medicines, health history, and cannabis use together. This is not a reason to stop a prescription, change its dose, or substitute cannabis without medical guidance. The evidence summarized here cannot support those decisions.

When a substance use disorder and another health condition occur together, NIDA generally supports treating the conditions together rather than leaving one unaddressed. Recovery care and medical care therefore serve complementary purposes. Addressing difficulty controlling cannabis use does not require ignoring pain, and addressing pain does not remove the need to consider cannabis-related concerns.

What does research establish and leave uncertain about cannabis use during pregnancy?

Research links cannabis use during pregnancy with outcomes such as lower birth weight and preterm birth, but it cannot predict an individual pregnancy. Using cannabis for nausea or pain does not establish pregnancy safety. Checking online recovery health claims and our cannabis use disorder overview help separate medical-sounding claims from appropriate care decisions.

NIDA's pregnancy summary reports links between prenatal cannabis use and lower birth weight, preterm birth, and other negative outcomes. It also describes concern about the developing brain. These are reasons to take exposure seriously, while avoiding the claim that a particular outcome is inevitable or can be attributed to cannabis alone.

The distinction between symptom relief and pregnancy safety is especially relevant to nausea. Research on cannabis or cannabinoid medicines for chemotherapy-related nausea concerns a different clinical situation. It does not establish that cannabis is an appropriate treatment for nausea during pregnancy. A benefit demonstrated for one condition or population cannot automatically be transferred to another.

NIDA reports that the American College of Obstetricians and Gynecologists recommends counseling against cannabis use while trying to become pregnant, during pregnancy, and while breastfeeding. That recommendation reflects potential harm; it is not dependent on proving that every exposed pregnancy will have a complication.

Important questions remain about how early exposure relates to later development. NIDA describes ongoing long-term research following families from pregnancy through childhood to better understand cannabis exposure alongside other substances, stressors, and life circumstances. Ongoing research is a sign that the evidence is still developing, not evidence that an exposure has been established as safe.

If cannabis use has already occurred, a population-level finding cannot determine what has happened in that pregnancy. The appropriate focus is supportive prenatal care and an honest discussion of symptoms and substance use, without assuming an outcome or assigning blame. Pregnancy-related evaluation belongs with qualified medical professionals. Substance use support may address a separate need, but it does not replace prenatal assessment or establish a pregnancy-care service at an outpatient recovery program.

Frequently asked questions about cannabis and physical health

Can cannabis increase heart rate and blood pressure shortly after use?

Yes. NIDA states that cannabis can increase heart rate and blood pressure right after use. These immediate changes are different from a diagnosis of cardiovascular disease. Their significance depends on the person's medical circumstances, and neither a noticeable effect nor its absence can establish overall cardiovascular safety.

Does an association with heart disease prove cannabis is the only cause?

No. An association shows a relationship in the people studied, but it does not by itself identify cannabis as the only cause. NIDA says more research is needed to determine whether there is a direct connection with cardiovascular disease or whether other factors contribute. Uncertainty also does not establish an absence of risk.

Does cannabis smoke contain some of the same harmful substances as tobacco smoke?

Yes. NIDA reports that cannabis smoke contains many of the same toxins, irritants, and cancer-causing substances as tobacco smoke. Smoking cannabis can harm lung tissue and is associated with airway problems. Shared substances do not establish identical risks, and tobacco co-use makes some long-term cannabis findings harder to interpret.

Can cannabis interact with medicines taken by older adults?

Yes. NIDA identifies possible interactions with medicines such as warfarin, opioids, and benzodiazepines that older adults may take. This is not a complete list or a prediction of the same effect in everyone. A clinician needs the actual medication and health history to assess the concern; general information cannot justify prescription changes.

Does using cannabis for a health symptom establish that it is appropriate during pregnancy?

No. A reason for using cannabis, including nausea or pain, does not establish pregnancy safety. Evidence from another medical setting cannot automatically be applied to pregnancy. NIDA reports links with adverse birth outcomes and describes professional recommendations against use during pregnancy. Prenatal clinicians can address symptoms and exposure concerns without presuming a particular outcome.

Sources

If you want support with cannabis use, you can explore Choice's Intensive Outpatient Program (IOP) in Albuquerque, NM, which includes weekly group and individual therapy, or contact Choice Recovery Path to discuss current outpatient options. You do not need to have every detail settled before starting a conversation.

Accessibility tools

Choose the adjustments you need. Your choices are saved on this browser when storage is available.

Accessibility Statement